产品和服务 / 产品类型 / ELISA试剂盒 / ELISA 抗体对
* This package insert must be read in its entirety before using this product.
Human Hyaluronidase 1/HYAL1 Multiplex/ELISA
Recommended Concentration | Sample | ||
---|---|---|---|
Multiplex | Capture | 3-20ug/mL | Rabbit anti-Human Hyaluronidase 1/HYAL1 mAb(Cat. No.RMK0447) |
Detection | 0.017-2ug/mL | Rabbit anti-Human Hyaluronidase 1/HYAL1 mAb(Cat. No.RMK0008) | |
Standard | 6.86-5000pg/mL | Recombinant Human Hyaluronidase 1/HYAL1 | |
ELISA | Capture | 1-4ug/mL | Rabbit anti- Human Hyaluronidase 1(Cat. No.RMK0007) |
Detection | 0.01-0.0025ug/mL | Rabbit anti- Human Hyaluronidase 1(Cat. No.RMK0008) | |
Standard | 0.15-10ng/mL | Recombinant Human Hyaluronidase 1 |
Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19.